semi-quantitative hiv-1 mutation analysis using the murex-innogenetics lipa hiv-1 rt assay.

NLM AIDSLINE Semi-quantitative HIV-1 mutation analysis using the Murex-Innogenetics LiPA HIV-1 RT assay. Sheridan F; Parker D; Shuurman R; De Graaf L; Tijnagel J; Boucher C;
December 30, 1998

Int Conf AIDS. 1998;12:787 (abstract no. 41225). Unique Identifier : BACKGROUND: A line probe assay has been developed for the simultaneous detection of the common mutations of the reverse transcriptase gene of HIV-1 which have been associated with resistance to zidovudine (AZT), lamivudine (3TC), didanosine (ddI) and zalcitabine (ddC). The assay detects the presence of both consensus wild type and resistant genotypes at codons 41, 69, 70, 74, 75, 184 & 215. The test is based on the amplification of the reverse transcriptase gene using biotinylated primers followed by reverse hybridisation of the amplicon with a series of complementary probes bound to a nitro-cellulose strip. Signal generation is accomplished using a streptavidin-alkaline phosphatase conjugate and BCIP/NBT substrate. We assessed the ability of LiPA HIV-1 RT to determine if an increase in the proportion of resistant virus for a particular codon correlates with increase in viral load. METHODS: Plasma samples from 19 patients were tested using the Murex-Innogenetics HIV-1 RT LiPA assay and Roche Amplicor HIV-1 Monitor viral load test. A semi-quantitative estimate of LiPA signal intensity at each codon was determined. RESULTS: The results show a correlation between an increasing viral load and the emergence of mutations which are associated with resistance to AZT. LiPA analysis illustrates the presence of a mixture of mutant and wild type consensus sequence in the plasma virus population. The subsequent outgrowth of mutant virus as the apparently dominant quasi-species as measured by relative LiPA signal intensity correlated with an increase in the viral load. CONCLUSIONS: Our results suggest that the signal intensity of both wild type and resistant lines on the LiPA strip may be used to determine the relative proportions of wild type and mutant virus present in the total virus population. The relative increase in signal intensity of the mutant probe compared to the wild type probe correlates with outgrowth of the resistant species which in turn accounts for an increase in viral load. MEETING ABSTRACTS Anti-HIV Agents/PHARMACOLOGY Drug Resistance, Microbial/GENETICS Human HIV Infections/BLOOD/VIROLOGY HIV-1/ENZYMOLOGY/GENETICS HIV-1 Reverse Transcriptase/GENETICS Mutation Nucleic Acid Hybridization Reagent Kits, Diagnostic Reverse Transcriptase Inhibitors/PHARMACOLOGY Zidovudine/PHARMACOLOGY

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Photographs from A Day with HIV Now Online Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 HIV messages should include MSM Stock-outs must be top of agenda TEXAS: Free HIV Testing CALIFORNIA: Entertainment AIDS Alliance (EAA) Presents 11th Annual Wine and Wisdom Fundraiser NORTH CAROLINA: ALFA Offers Free Community Health Educator Training in Hickory CALIFORNIA: Over Half of People Living with AIDS in San Francisco Are Aged 50 or Older THAILAND; UNITED STATES: HIV Drug Can Also Protect Injection Drug Users INDONESIA: Growing HIV/AIDS Awareness in Indonesia's Papua Region UNITED STATES: Many Young Americans Unaware They're Infected with HIV Board to Vote on Condoms in Boston Schools HIV messages should include MSM TEXAS: Free HIV Testing THAILAND; UNITED STATES: HIV Drug Can Also Protect Injection Drug Users INDONESIA: Growing HIV/AIDS Awareness in Indonesia's Papua Region UNITED STATES: Many Young Americans Unaware They're Infected with HIV New International Report on HIV Prevention Urges Localized Consideration of Antiretroviral Strategies New Analysis of World's Premier AIDS Conference Finds Poor Coverage of Populations Most-at-Risk for HIV GREECE: Doubled HIV Cases Add to Greek Woes OHIO: Phila Health Department HIV Testing Well-Received CONNECTICUT: City's Circle Care Center is a Model for HIV Prevention
Information in this article was accurate in December 30, 1998. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.